Sign inJoin waitlistJoin the waitlist

Paolo Mannelli

Professor of Psychiatry and Behavioral Sciences · Duke University Hospital

Credentials: · ·

History

Psychiatry
University of California-San Francisco
1989–1990
Catholic University of the Sacred Heart–Rome
1986–1990
Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia 'Agostino Gemelli'
1982–1986

Research

Pre-treatment measures of impulsivity, aggression and sensation seeking are associated with treatment outcome for African-American cocaine-dependent patients
Journal of Addictive Diseases · 2004 · 109 citations
A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression
Journal of Clinical Psychopharmacology · 2006 · 104 citations
Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients
Drug and Alcohol Dependence · 2018 · 82 citations

AP
Ashwin Patkar
43 papers
EG
Edward Gottheil
8 papers
Marvin Swartz
8 papers
Wade Berrettini
7 papers
David Gorelick
6 papers
MV
Michael Vergare
6 papers
DB
Dan Blazer
5 papers
Kevin Hill
5 papers
Maria Sullivan
5 papers
DM
David Marks
4 papers
SA
Sarah Akerman
4 papers
AZ
Abigail Zavod
3 papers

Grants

Targeting Reinforcement Mechanisms for Smoking Cessation Using Very Low Nicotine Content Cigarettes in Individuals with Opioid Use Disorder and Chronic Pain
National Institute on Drug Abuse · R34
PI · $724.5K · Duke University
2024–2027
Place of Low-Dose Naltrexone in Opiate Detoxification
National Institute on Drug Abuse · R21
Contact PI · $557.2K · Duke University
2003–2006

Clinical trials

Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075
Principal investigator · Completed · Early phase 1
Duke University
2018–2019
Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence
Principal investigator · Completed · Phase 2
Paolo Mannelli
2012–2015
Addition of Naltrexone to Methadone Taper
Principal investigator · Completed · Phase 2
National Institute on Drug Abuse (NIDA)
2005–2006